AN ACT relating to coverage for hearing loss.
SB 93 expands Kentucky insurance coverage requirements for hearing loss-related care. The bill amends state law to require health benefit plans to cover hearing aids and related services for children with documented hearing loss, with no cost sharing, and sets a minimum coverage amount of at least $2,500 per hearing aid. It also revises the cochlear implant mandate so that health plans must cover cochlear implants without cost sharing at least to the level of Medicare national coverage determinations and reasonable and customary costs, while preserving prior-law minimums. The bill directs the insurance commissioner to adopt and annually review regulations setting minimum coverage amounts and allows consumers to pay the difference if they choose a higher-priced device.
The bill extends these hearing-loss coverage requirements to Medicaid, KCHIP, the state employee health plan, and certain public postsecondary institution plans by cross-referencing the new mandates in those programs’ governing statutes. It also includes provisions for network adequacy, requiring insurers using networks to maintain reasonably adequate access to hearing-aid services and, at minimum, an adequate number of accessible pediatric audiologists. The bill contains standard high-deductible health plan carveouts, federal compliance language, and implementation provisions tied to possible federal waivers or determinations about essential health benefits.
In practical terms, SB 93 would increase the scope and floor of hearing-related benefits in Kentucky’s regulated health plans and public coverage programs, likely raising insurer and public-program costs while improving access for children and other covered enrollees who need hearing aids or cochlear implants. It amends multiple statutes in KRS Chapters 304, 205, 164, and 18A, and it specifically updates the state employee health insurance program to include the new hearing-loss mandates among its required benefits.
The overall sentiment reflected in the available voting history is strongly supportive: the Senate passed the bill 38-0 on third reading, indicating unanimous approval among voting senators. No committee transcript excerpts were provided, so there is no recorded floor or committee debate in the supplied materials to suggest organized opposition.
The main points of potential contention are cost and implementation. The bill requires no cost sharing for the mandated hearing-aid and cochlear-implant coverage, sets a minimum hearing-aid coverage amount, and requires network adequacy standards, all of which could increase premiums or administrative burdens for insurers and public plans. It also raises federal-law questions for qualified health plans and Medicaid/KCHIP implementation, which is why the bill includes waiver and federal-approval provisions. However, the available record does not show any active opposition in the chamber vote.
SB 93 amends Kentucky insurance and public-benefit statutes to require broader hearing-loss coverage in private health benefit plans and in several public coverage programs, including Medicaid, KCHIP, the state employee health plan, and certain public postsecondary institution plans. It creates or updates statutory mandates for hearing aids, related services, and cochlear implants, directs the Department of Insurance to promulgate and review minimum coverage regulations, and adds network adequacy requirements for plans that use provider networks. The bill is set to apply to health benefit plans issued or renewed on or after January 1, 2026, with additional federal-compliance and waiver provisions to address essential health benefits and possible funding issues.
The available voting record shows clear, unanimous support in the Senate, with a 38-0 third-reading vote. No committee discussion excerpts were provided, so the record does not show detailed debate, but the vote suggests the bill was viewed favorably and without visible controversy among senators. The bill’s subject matter—expanding access to hearing aids and cochlear implants for children and other covered populations—appears to have broad bipartisan appeal in the available materials.
The likely areas of contention are fiscal and administrative rather than policy direction. Insurers, public employers, and state health programs may object to the added coverage mandates, no-cost-sharing requirements, and network adequacy obligations because they can increase costs and require plan redesign. There is also a federal-law implementation issue: the bill anticipates that some requirements may be treated as additional essential health benefits for qualified health plans, triggering waiver or cost-defrayal steps. No specific opposing speakers or amendments are included in the provided record, so these concerns are inferred from the bill’s structure rather than documented debate.